Recent Analysts’ Ratings Changes for Welltower (WELL)

Several brokerages have updated their recommendations and price targets on shares of Welltower (NYSE: WELL) in the last few weeks:

  • 12/22/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 12/20/2025 – Welltower was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating.
  • 12/18/2025 – Welltower had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $205.00 price target on the stock.
  • 12/15/2025 – Welltower had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $231.00 price target on the stock.
  • 12/15/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 12/8/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 12/4/2025 – Welltower had its price target raised by analysts at UBS Group AG from $203.00 to $232.00. They now have a “buy” rating on the stock.
  • 12/1/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/25/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/25/2025 – Welltower had its price target raised by analysts at Wells Fargo & Company from $200.00 to $218.00. They now have an “overweight” rating on the stock.
  • 11/22/2025 – Welltower was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating.
  • 11/20/2025 – Welltower had its price target raised by analysts at Morgan Stanley from $170.00 to $200.00. They now have an “overweight” rating on the stock.
  • 11/19/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/13/2025 – Welltower had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/13/2025 – Welltower had its price target raised by analysts at Scotiabank from $182.00 to $214.00. They now have a “sector outperform” rating on the stock.
  • 11/1/2025 – Welltower was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating.
  • 10/29/2025 – Welltower was given a new $196.00 price target on by analysts at Loop Capital.
  • 10/29/2025 – Welltower was given a new $203.00 price target on by analysts at UBS Group AG.
  • 10/28/2025 – Welltower had its price target raised by analysts at UBS Group AG from $195.00 to $203.00. They now have a “buy” rating on the stock.
  • 10/28/2025 – Welltower had its price target raised by analysts at Cantor Fitzgerald from $195.00 to $200.00. They now have an “overweight” rating on the stock.

Welltower Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 20th. Investors of record on Tuesday, November 11th were paid a $0.74 dividend. The ex-dividend date of this dividend was Monday, November 10th. This represents a $2.96 dividend on an annualized basis and a yield of 1.6%. Welltower’s payout ratio is presently 204.14%.

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.

Featured Articles

Receive News & Ratings for Welltower Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower Inc and related companies with MarketBeat.com's FREE daily email newsletter.